Leidos Awarded CDC’s National Healthcare Safety Network Modernization Contract

Rhea-AI Summary

Leidos (NYSE:LDOS) has been awarded the National Healthcare Safety Network (NHSN) Development, Maintenance, Support, and Modernization contract by the CDC's National Center for Emerging and Zoonotic Infectious Diseases. The contract, valued at $51 million over five years, involves Leidos leveraging its data management and mission software expertise to maintain and enhance the NHSN platform.

NHSN is a critical system that serves nearly all U.S. healthcare facilities, including hospitals, nursing homes, and dialysis centers. It facilitates electronic messaging from health records, informs infection prevention, monitors healthcare system capacity, tracks vaccination uptake, and helps prevent the spread of threats like COVID-19 and antimicrobial-resistant infections.

Leidos will work on advancing and modernizing the NHSN application, which currently empowers over 160,000 users at more than 38,000 facilities with reliable data, driving improvements in patient outcomes and system efficiency.

Positive

• Secured a $51 million contract over five years with the CDC
• Continuation and expansion of long-standing partnership with CDC since 2003
• Opportunity to modernize and advance a critical healthcare data platform
• Serves nearly all U.S. healthcare facilities, indicating wide market reach

Negative

• None.

News Market Reaction

+1.23%

1 alert

+1.23% News Effect

On the day this news was published, LDOS gained 1.23%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

RESTON, VA / ACCESSWIRE / October 1, 2024 /Leidos (NYSE:LDOS), a Fortune® 500 innovation company, was recently awarded the National Healthcare Safety Network (NHSN) Development, Maintenance, Support, and Modernization contract by the Centers for Disease Control and Prevention's (CDC's) National Center for Emerging and Zoonotic Infectious Diseases. Leidos will leverage its data management and mission software expertise to continue delivering a secure NHSN platform, including the necessary support applications and inputs from partnering federal agencies. The contract has a total value of $51 million over a five-year period of performance.

"NHSN is a critical cornerstone in enhancing patient safety and healthcare delivery across the U.S.," said Liz Porter, Leidos Health & Civil Sector president. "Since the inception of NHSN in 2003, our collaboration with the CDC has empowered over 160,000 users at more than 38,000 facilities with reliable and actionable data. Our combined efforts ensure the secure transmission of healthcare data across evolving sites of care, driving improvements in patient outcomes and fostering system modernization and efficiency."

Leidos will work to continue to advance and modernize the NHSN application. NHSN facilitates electronic messaging directly from electronic health records; informs rapid, tailored infection prevention; and allows decision-makers to monitor healthcare system capacity. Additionally, the platform tracks vaccination uptake in healthcare settings, monitors blood safety errors, and helps prevent the spread of emerging and enduring threats, such as COVID-19, healthcare associated infections, and antimicrobial-resistant infections.

The NHSN serves nearly all U.S. hospitals, nursing homes, dialysis facilities, and ambulatory surgery centers. This contract will extend Leidos' support in providing the critical data necessary to understand the success of prevention efforts and practices in healthcare, ultimately determining the quality and safety of care delivered in U.S. healthcare facilities.

View additional multimedia and more ESG storytelling from Leidos on 3blmedia.com.

Contact Info:

Spokesperson: Leidos
Website: https://www.3blmedia.com/profiles/leidos
Email: info@3blmedia.com

SOURCE: Leidos

View the original press release on accesswire.com

FAQ

What is the value and duration of the NHSN contract awarded to Leidos (LDOS)?

The NHSN contract awarded to Leidos (LDOS) has a total value of $51 million over a five-year period of performance.

How many facilities and users does the NHSN platform currently serve?

The NHSN platform currently serves over 160,000 users at more than 38,000 facilities across the United States.

What types of healthcare facilities does the NHSN platform cover?

The NHSN platform serves nearly all U.S. hospitals, nursing homes, dialysis facilities, and ambulatory surgery centers.

What are some key functions of the NHSN platform that Leidos (LDOS) will be maintaining and modernizing?

Key functions include facilitating electronic messaging from health records, informing infection prevention, monitoring healthcare system capacity, tracking vaccination uptake, and helping prevent the spread of threats like COVID-19 and antimicrobial-resistant infections.